GL1X · GenesisL1 explorer

Research workbench

Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC protein-protein interaction

Analyse Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6U5Y
Type
protein
Length
608 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Wd repeat-containing protein 5
UniProt
P61964
Ligands
Q0M
Pockets
6 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 0% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BWd repeat-containing protein 5protein3040% helix, 52% strandP61964

Ligands and binding sites

  • Q0M · 3-{[(5-bromo-3-chloro-2-hydroxyphenyl)sulfonyl]amino}-5-(1-cyanocyclobutyl)-2-hydroxy-N-methylbenzamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14980.740.8346empty
24880.730.8242empty
31630.500.7821empty
41800.500.7720empty
5660.340.7616Q0M

Interfaces

1 interface between chains.

  • A–B · 555 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 6U5Y · Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.